Sona Nanotech preclinical study shows tumor regression in colorectal cancer model

Sona Nanotech Inc (CSE:SONA, OTCQB:SNANF) has announced the publication of a preclinical study examining the efficacy of its Targeted Hyperthermia Therapy...